Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.' - 2The Starbucks for Life game is back, along with your chance to win a 'Bearista' cold cup. Here's how to get your paws on one.
- 3Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- 4Unsold Rams May Be Less expensive Than You Suspect
- 5Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- What is the Significant Tech Expertise to Master Today?
- 10 Delectable Specialty Mixed drinks
- Figure out How to Amplify the Resale Worth of Your Kona SUV
- Ancient eggshells shed new light on crocodiles that hunted prey from trees
- The Extraordinary Excursion of Dental Embed Innovation
- Find the Historical backdrop of Common liberties: Advancing Equity and Equity Around the world
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- California officials warn against foraging wild mushrooms after deadly poisoning outbreak
